When to Resume Sexual Contact After Trichomoniasis Treatment
Patients treated for trichomoniasis should abstain from sexual intercourse until both they and their sex partners have completed therapy and are asymptomatic. 1
Timing Based on Treatment Regimen
Single-Dose Metronidazole (2 g)
- Wait until therapy is completed and both patient and partner are asymptomatic before resuming sexual activity. 1
- In practical terms, this means waiting at least 7 days after the single dose to ensure adequate drug levels have been maintained and symptoms have resolved. 2
Multi-Dose Metronidazole (500 mg twice daily for 7 days)
- Abstain from sexual intercourse for 7 days after therapy is initiated, provided symptoms have resolved and sex partners have been adequately treated. 3, 2
- This 7-day waiting period applies from the start of treatment, not from completion. 3, 2
Tinidazole (2 g single dose)
- Follow the same guidance as single-dose metronidazole: wait until therapy is completed and both patient and partner are asymptomatic. 1
- The FDA label for tinidazole does not specify a different waiting period than metronidazole. 4
Critical Partner Management Requirements
Both the patient and all sex partners must complete treatment before resuming sexual activity. 1, 5 This is non-negotiable because:
- Trichomoniasis is a sexually transmitted infection, and untreated partners will reinfect the treated patient. 1, 5
- Reinfection rates are significantly higher when partners remain untreated—one study showed relapse rates of 23.7% with untreated partners versus 5.1% with treated partners (p=0.01). 6
- Asymptomatic male partners are common carriers and can be difficult to diagnose, yet they remain infectious. 5
Practical Algorithm for Resuming Sexual Activity
Confirm both patient and partner(s) have completed the full treatment course (either single-dose or 7-day regimen). 1
Verify symptom resolution in the patient (discharge, irritation, odor have resolved). 1
Wait the appropriate time period:
Ensure partner treatment is documented or directly observed when possible, as partner non-compliance is a major cause of reinfection. 6, 7
Common Pitfalls to Avoid
Do not allow resumption of sexual activity if the partner has not been treated, even if the patient is asymptomatic—this leads to immediate reinfection. 1, 5, 6
Do not rely on negative cultures or smears in male partners to determine if treatment is needed; there is considerable difficulty isolating the organism from asymptomatic male carriers, and negative tests cannot be relied upon. 5
Do not assume condom use alone is sufficient protection during the treatment period—complete abstinence until both partners are treated and asymptomatic is the standard. 1
Do not forget to counsel about alcohol abstinence during metronidazole therapy and for 24 hours after the last dose, as this can cause severe disulfiram-like reactions. 8
Test-of-Cure Considerations
Routine follow-up is unnecessary for patients who become asymptomatic after treatment. 1
If test-of-cure is performed, wait at least 3 weeks after completing multi-dose metronidazole or 4 weeks after single-dose metronidazole before testing with nucleic acid amplification tests (NAAT) to avoid detecting remnant non-viable nucleic acid. 9
Rescreening at 3 months after treatment is recommended due to high rates of reinfection (11-19% in recent trials), regardless of whether partners report being treated. 10, 11
Special Considerations for Treatment Failure
If symptoms persist or recur after treatment and reinfection has been excluded, consider metronidazole-resistant Trichomonas vaginalis (MLC ≥50 μg/mL for metronidazole or ≥6.3 μg/mL for tinidazole). 12
In cases of treatment failure, re-treat with metronidazole 500 mg twice daily for 7 days, and if this fails, consider tinidazole or higher-dose metronidazole regimens. 1, 13
Late recurrence after initial successful treatment (even months later) with an untreated partner strongly suggests reinfection rather than relapse. 7